Label: MAJOR TRIPLE ANTIBIOTIC- bacitracin zinc, neomycin, polymyxin b sulfat ointment
- NDC Code(s): 0904-8805-67
- Packager: Major Pharmaceuticals
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 15, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredient
- Purpose
- Active ingredient
- Purpose
- Active Ingredient
- Purpose
- Uses
- Warnings
- Ask Doctor before use if you have
- Do Not Use
- Stop Use and Ask Doctor if
- Directions
- Inactive Ingredients
- Questions
- Storage Information
- Keep out of reach of children
- Other Information
- Packaging
-
INGREDIENTS AND APPEARANCE
MAJOR TRIPLE ANTIBIOTIC
bacitracin zinc, neomycin, polymyxin b sulfat ointmentProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:0904-8805 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NEOMYCIN SULFATE (UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297) NEOMYCIN 3.5 mg in 1 g BACITRACIN ZINC (UNII: 89Y4M234ES) (BACITRACIN - UNII:58H6RWO52I) BACITRACIN 400 [USP'U] in 1 g POLYMYXIN B SULFATE (UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K) POLYMYXIN B 5000 [USP'U] in 1 g Inactive Ingredients Ingredient Name Strength MINERAL OIL (UNII: T5L8T28FGP) PETROLATUM (UNII: 4T6H12BN9U) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0904-8805-67 144 in 1 CARTON 05/29/2020 1 0.9 g in 1 PACKET; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M004 04/20/2020 Labeler - Major Pharmaceuticals (191427277) Registrant - Trifecta Pharmaceuticals USA LLC (079424163)